The Experts below are selected from a list of 6348 Experts worldwide ranked by ideXlab platform

Amir Mohammad Ataei - One of the best experts on this subject based on the ideXlab platform.

  • anti HEpatitis E Antibody in hEmodialysis patiEnts in isfahan iran prEvalEncE and risk factors
    Hepatitis Monthly, 2015
    Co-Authors: Seyed Moayed Alavian, Behrooz Ataei, Ali Ebrahimi, Omid Pirhaji, Roya Azad, Behrooz Olya, Amir Mohammad Ataei
    Abstract:

    of thE HD patiEnts. REsults: Anti-HEV IgG was dEtEctEd in 27 (9.9%) controls and 78 (28.3%) patiEnts, with thE diffErEncE bEing statistically significant (P < 0.05). FurthErmorE, thErE was a significant association bEtwEEn positivE anti-HEV Antibody, HD duration, and blood transfusion history in thE HD patiEnts. Conclusions: ConsidEring thE rEsults, it sEEms nEcEssary to conduct prospEctivE studiEs in ordEr to idEntify factors rEsponsiblE for thE high sEroprEvalEncE of HEV in Isfahan HD units.

Seyed Moayed Alavian - One of the best experts on this subject based on the ideXlab platform.

  • anti HEpatitis E Antibody in hEmodialysis patiEnts in isfahan iran prEvalEncE and risk factors
    Hepatitis Monthly, 2015
    Co-Authors: Seyed Moayed Alavian, Behrooz Ataei, Ali Ebrahimi, Omid Pirhaji, Roya Azad, Behrooz Olya, Amir Mohammad Ataei
    Abstract:

    of thE HD patiEnts. REsults: Anti-HEV IgG was dEtEctEd in 27 (9.9%) controls and 78 (28.3%) patiEnts, with thE diffErEncE bEing statistically significant (P < 0.05). FurthErmorE, thErE was a significant association bEtwEEn positivE anti-HEV Antibody, HD duration, and blood transfusion history in thE HD patiEnts. Conclusions: ConsidEring thE rEsults, it sEEms nEcEssary to conduct prospEctivE studiEs in ordEr to idEntify factors rEsponsiblE for thE high sEroprEvalEncE of HEV in Isfahan HD units.

Behrooz Olya - One of the best experts on this subject based on the ideXlab platform.

  • anti HEpatitis E Antibody in hEmodialysis patiEnts in isfahan iran prEvalEncE and risk factors
    Hepatitis Monthly, 2015
    Co-Authors: Seyed Moayed Alavian, Behrooz Ataei, Ali Ebrahimi, Omid Pirhaji, Roya Azad, Behrooz Olya, Amir Mohammad Ataei
    Abstract:

    of thE HD patiEnts. REsults: Anti-HEV IgG was dEtEctEd in 27 (9.9%) controls and 78 (28.3%) patiEnts, with thE diffErEncE bEing statistically significant (P < 0.05). FurthErmorE, thErE was a significant association bEtwEEn positivE anti-HEV Antibody, HD duration, and blood transfusion history in thE HD patiEnts. Conclusions: ConsidEring thE rEsults, it sEEms nEcEssary to conduct prospEctivE studiEs in ordEr to idEntify factors rEsponsiblE for thE high sEroprEvalEncE of HEV in Isfahan HD units.

Roya Azad - One of the best experts on this subject based on the ideXlab platform.

  • anti HEpatitis E Antibody in hEmodialysis patiEnts in isfahan iran prEvalEncE and risk factors
    Hepatitis Monthly, 2015
    Co-Authors: Seyed Moayed Alavian, Behrooz Ataei, Ali Ebrahimi, Omid Pirhaji, Roya Azad, Behrooz Olya, Amir Mohammad Ataei
    Abstract:

    of thE HD patiEnts. REsults: Anti-HEV IgG was dEtEctEd in 27 (9.9%) controls and 78 (28.3%) patiEnts, with thE diffErEncE bEing statistically significant (P < 0.05). FurthErmorE, thErE was a significant association bEtwEEn positivE anti-HEV Antibody, HD duration, and blood transfusion history in thE HD patiEnts. Conclusions: ConsidEring thE rEsults, it sEEms nEcEssary to conduct prospEctivE studiEs in ordEr to idEntify factors rEsponsiblE for thE high sEroprEvalEncE of HEV in Isfahan HD units.

Omid Pirhaji - One of the best experts on this subject based on the ideXlab platform.

  • anti HEpatitis E Antibody in hEmodialysis patiEnts in isfahan iran prEvalEncE and risk factors
    Hepatitis Monthly, 2015
    Co-Authors: Seyed Moayed Alavian, Behrooz Ataei, Ali Ebrahimi, Omid Pirhaji, Roya Azad, Behrooz Olya, Amir Mohammad Ataei
    Abstract:

    of thE HD patiEnts. REsults: Anti-HEV IgG was dEtEctEd in 27 (9.9%) controls and 78 (28.3%) patiEnts, with thE diffErEncE bEing statistically significant (P < 0.05). FurthErmorE, thErE was a significant association bEtwEEn positivE anti-HEV Antibody, HD duration, and blood transfusion history in thE HD patiEnts. Conclusions: ConsidEring thE rEsults, it sEEms nEcEssary to conduct prospEctivE studiEs in ordEr to idEntify factors rEsponsiblE for thE high sEroprEvalEncE of HEV in Isfahan HD units.